SCHEMBL6132047

SCHEMBL6132047

COc1cccc(-c2[nH]ncc2-c2ccc(N(C)C)cc2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.57
MEN1 O00255 4/20 0.52
GFER P55789 1/20 0.52
TGFBR1 P36897 1/20 0.51
HTR1A P08908 2/20 0.49
HTR7 P34969 2/20 0.49
HTR2B P41595 2/20 0.49
HTR3A P46098 2/20 0.49
HTR2A P28223 1/20 0.49
HTR2C P28335 1/20 0.49
HTR6 P50406 1/20 0.49
GSK3B P49841 1/20 0.48
MAPT P10636 2/20 0.48
ALOX15 P16050 1/20 0.48
ALOX12 P18054 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
GAA P10253 2/20 0.47
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6132077 0.79 TGFBR1 (0.56) KMT2AMEN1GFERTGFBR1HTR1A
SCHEMBL14266224 0.77 ABL1 (0.55) GSK3BMAPTALDH1A1LMNA
SCHEMBL6132089 0.75 TDP1 (0.54) KMT2AMEN1GFERTGFBR1HTR1A
SCHEMBL9127973 0.74 KMT2A (1.00) KMT2AMEN1GFERTGFBR1HTR1A
SCHEMBL1250064 0.73 RAB9A (0.58) KMT2AMEN1GSK3BMAPTALOX15
SCHEMBL26452836 0.71 HTR1A (0.54) KMT2AMEN1GFERTGFBR1HTR1A
SCHEMBL28405717 0.71 TGFBR1 (0.56) KMT2AMEN1GFERTGFBR1HTR1A
SCHEMBL4177085 0.71 MAPT (0.71) KMT2AGFERTGFBR1HTR1AHTR7
SCHEMBL1250845 0.70 KDM4E (0.73) KMT2AMEN1MAPTALOX15NPSR1
SCHEMBL6132034 0.70 KMT2A (0.49) KMT2AMEN1TGFBR1HTR7GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1435957-A4 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMA (US) 2005-04-13 EP claimed
EP-1435957-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES Vertex Pharmaceuticals Incorporated (US) 2004-07-14 EP claimed
WO-2002088078-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-11-07 WO claimed